I agree the FDA likes leronlimab, with the great s
Post# of 148326
https://www.cnbc.com/2019/04/08/zogenix-plumm...tment.html
Zogenix plummets 30% after FDA refuses to review its seizure treatment
Kind of like my initial thought reading a long's posts this morning:
"With shareholders like this, who needs enemies."